- Home
- IMMP vs BNTC Comparison
IMMP vs BNTC Comparison
Compare IMMP & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- BNTC
- Stock Information
- Founded
- IMMP 1987
- BNTC 1995
- Country
- IMMP Australia
- BNTC United States
- Employees
- IMMP N/A
- BNTC N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- IMMP Health Care
- BNTC Health Care
- Exchange
- IMMP Nasdaq
- BNTC Nasdaq
- Market Cap
- IMMP 304.0M
- BNTC 339.8M
- IPO Year
- IMMP N/A
- BNTC N/A
- Fundamental
- Price
- IMMP $1.91
- BNTC $15.66
- Analyst Decision
- IMMP Buy
- BNTC Strong Buy
- Analyst Count
- IMMP 2
- BNTC 7
- Target Price
- IMMP $8.50
- BNTC $24.43
- AVG Volume (30 Days)
- IMMP 72.7K
- BNTC 37.6K
- Earning Date
- IMMP 03-25-2025
- BNTC 05-12-2025
- Dividend Yield
- IMMP N/A
- BNTC N/A
- EPS Growth
- IMMP N/A
- BNTC N/A
- EPS
- IMMP N/A
- BNTC N/A
- Revenue
- IMMP $3,019,249.00
- BNTC N/A
- Revenue This Year
- IMMP N/A
- BNTC N/A
- Revenue Next Year
- IMMP $20.28
- BNTC N/A
- P/E Ratio
- IMMP N/A
- BNTC N/A
- Revenue Growth
- IMMP 24.11
- BNTC N/A
- 52 Week Low
- IMMP $1.65
- BNTC $4.75
- 52 Week High
- IMMP $3.34
- BNTC $15.97
- Technical
- Relative Strength Index (RSI)
- IMMP 54.87
- BNTC 73.53
- Support Level
- IMMP $1.65
- BNTC $11.99
- Resistance Level
- IMMP $1.88
- BNTC $15.97
- Average True Range (ATR)
- IMMP 0.08
- BNTC 1.03
- MACD
- IMMP 0.01
- BNTC 0.33
- Stochastic Oscillator
- IMMP 89.66
- BNTC 93.76
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.